 |
|
|
|
 |
Peter T. Scardino, FACS
 |
Peter T. Scardino, FACS Chair, Department of Surgery; David H. Koch Chair
|
|
|
As Chairman of the Department of Surgery, I oversee a department widely recognized for its expertise and innovation in cancer surgery. In addition to my administrative responsibilities, I am a surgeon specializing in prostate cancer. My expertise is in early detection, prognosis, and surgical treatment of prostate cancer. Radical prostatectomy -- complete removal of the prostate -- can cure many men with prostate cancer. Our team has developed surgical techniques to preserve urinary and sexual function after prostatectomy, and we continue to seek ways to improve quality of life for patients after treatment.
Not all prostate cancers progress in the same way. Many cancers pose little or no threat to life and health, while others grow aggressively and are resistant to treatment. My colleagues and I have pioneered the use of statistical models to predict both the natural progression of prostate cancer and how it will respond to treatment. These predictive tools (nomograms) help us tailor treatment for individual men according to the specific characteristics of their cancer.
Today, nomograms are being used to help physicians and patients make medical decisions regarding a variety of other cancers, including pancreatic, lung, and breast cancer. Our prediction tools are available on our Web site at Prediction Tools.
In 2001, I received an NIH grant to establish an ongoing Specialized Program of Research Excellence (SPORE) in prostate cancer at MSKCC. Our SPORE has an ambitious research program focused on developing therapies appropriate for patients with different types of prostate cancer at different stages of development. We hope to achieve this by using molecular and genetic data to improve our prediction models for prostate cancer, identifying the critical mechanisms by which prostate cancer grows and spreads, and developing drugs and immunological techniques for treatment-resistant metastatic cancers.
My position at MSKCC includes appointments as Head of the Prostate Cancer Program and as the David H. Koch Chair. I am also a Professor in the Department of Urology at the Weill Medical College of Cornell University and at the State University of New York Downstate Medical Center.
I have written many articles and book chapters and edited the Comprehensive Textbook of Genitourinary Oncology. In 2005, with Judith Kelman, I wrote Dr. Peter Scardino's Prostate Book, a guide to prostate cancer, prostatitis, and benign prostate hyperplasia (BPH). I serve as Editor-in-Chief of Nature Clinical Practice Urology, and I am an editorial board member and reviewer for several peer-reviewed journals. I am an active member of the National Academies' Institute of Medicine and the of American Urological Association.
Appointments for New Patients
646-497-9068
Phone
646-422-4329
Education
MD, Duke University School of Medicine
Residencies
Massachusetts General Hospital; University of California, Los Angeles, School of Medicine
Fellowships
National Cancer Institute
Board Certifications
Urology
Clinical Expertise
Urologic Oncology; Prostate Cancer
Department & Service
|
|
|
|
|
|
